Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Big Pharma, Little Science? A bibliometric perspective on big pharma&apos, s R&amp, D decline

  • Ismael Rafols
  • Hopkins, M.M.
  • Hoekman, J.
  • Siepel, J.
  • O'Hare, A.
  • Perianes-Rodriguez, A.
  • Nightingale, P.
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characterised by stagnation in the numbers of new drug approvals in the face of increasing R&D costs. This study explores pharmaceutical R&D dynamics by examining the publication activities of all R&D laboratories of the major European and US pharmaceutical firms (Big Pharma) during the period 1995-2009. The empirical findings present an industry in transformation. In the first place, we observe a decline of the total number of publications by large firms. Second, we show a relative increase of their external collaborations suggesting a tendency to outsource, and a diversification of the disciplinary base, in particular towards computation, health services and more clinical approaches. Also evident is a more pronounced decline in publications by both R&D laboratories located in Europe and by firms with European headquarters. Finally, while publications by Big Pharma in emerging economies sharply increase, they remain extremely low compared with those in developed countries. In summary, the trend in this transformation is one of a gradual decrease in internal research efforts and increasing reliance on external research. These empirical insights support the view that Big Pharma are increasingly becoming 'network integrators' rather than the prime locus of drug discovery., We thank Mike O'Neill, Luigi Orsenigo and Sergio Sismondo for comments. Ismael Rafols and Alice O'Hare were funded by the EU FP7 project FRIDA(Grant 225546, http://www.fridaproject.eu) and the US NSF (Award no. 0830207, http://idr.gatech.edu/). Michael Hopkins and Josh Siepel were supported by ESRC grant RES-360-25-0076. Jarno Hoekman has been supported by the Netherlands Organisation for Scientific Research (NWO) under the VIDI programme, number 452-06-005. Antonio Perianes-Rodríguez conducted his research at the University of Sussex as awardee of José Castillejo grant, JC2010-0042, funded by the Spanish Ministry of Education. The findings and observations contained in this paper are those of the authors and do not necessarily reflect the views of the funders.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Interactive Overlay Maps for US Patent (USPTO) Data Based on International Patent Classifications (IPC)

  • Leydesdorff, L.
  • Kushnir, Duncan
  • Ismael Rafols
[EN] We report on the development of an interface to the US Patent and Trademark Office (USPTO) that allows for the mapping of patent portfolios as overlays to basemaps constructed from citation relations among all patents contained in this database during the period 1976-2011. Both the interface and the data are in the public domain; the freeware programs VOSViewer and/or Pajek can be used for the visualization. These basemaps and overlays can be generated at both the 3-digit and 4-digit levels of the International Patent Classification (IPC) of the world intellectual property organization (WIPO). The basemaps can provide a stable mental framework for analysts to follow developments over searches for different years, which can be animated. The full flexibility of the advanced search engines of USPTO are available for generating sets of patents and/or patent applications which can thus be visualized and compared. This instrument allows for addressing questions about technological distance, diversity in portfolios, and animating the developments of both technologies and technological capacities of organizations over time., We acknowledge support by the ESRC project 'Mapping the Dynamics of Emergent Technologies' (RES-360-25-0076). We are grateful to Nils Newman and Antoine Schoen for previous comments and communications.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Global Maps of Science based on the new Web-of-Science Categories

  • Leydesdorff, L.
  • Carley, S.
  • Ismael Rafols
[EN] In August 2011, Thomson Reuters launched version 5 of the Science and Social Science Citation Index in the Web of Science (WoS). Among other things, the 222 ISI Subject Categories (SCs) for these two databases in version 4 of WoS were renamed and extended to 225 WoS Categories (WCs). A new set of 151 Subject Areas was added, but at a higher level of aggregation. Perhaps confusingly, these Subject Areas are now abbreviated "SC'' in the download, whereas "WC'' is used for WoS Categories. Since we previously used the ISI SCs as the baseline for a global map in Pajek (Pajek is freely available at http://vlado.fmf.uni-lj.si/pub/networks/pajek/) (Rafols et al., Journal of the American Society for Information Science and Technology 61:1871-1887, 2010) and brought this facility online (at http://www.leydesdorff.net/overlaytoolkit), we recalibrated this map for the new WC categories using the Journal Citation Reports 2010. In the new installation, the base maps can also be made using VOSviewer (VOSviewer is freely available at http://www.VOSviewer.com/) (Van Eck and Waltman, Scientometrics 84:523-538, 2010)., We acknowledge support from the ESRC grant RES-360-25-0076
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Bibliometric perspectives on medical innovation using the medical subject Headings of Pubmed

  • Leydesdorff, L.
  • Rotolo, D.
  • Rafols García, Ismael
Multiple perspectives on the nonlinear processes of medical innovations can be distinguished and combined using the Medical Subject Headings (MeSH) of the MEDLINE database. Focusing on three main branches-"diseases," "drugs and chemicals," and "techniques and equipment"-we use base maps and overlay techniques to investigate the translations and interactions and thus to gain a bibliometric perspective on the dynamics of medical innovations. To this end, we first analyze the MEDLINE database, the MeSH index tree, and the various options for a static mapping from different perspectives and at different levels of aggregation. Following a specific innovation (RNA interference) over time, the notion of a trajectory which leaves a signature in the database is elaborated. Can the detailed index terms describing the dynamics of research be used to predict the diffusion dynamics of research results? Possibilities are specified for further integration between the MEDLINE database on one hand, and the Science Citation Index and Scopus (containing citation information) on the other. © 2012 ASIS&T., We acknowledge support by the ESRC project "Mapping the Dynamics of Emergent Technologies" (RES-360-25-0076). Ismael Rafols acknowledges funding from U.S. National Science Foundation (Award 0830207, "Measuring and Tracking Research Knowledge Integration"). The findings and observations contained in this article are those of the authors and do not necessarily reflect the views of the funding agencies. We are grateful to Lutz Bornmann and Tobias Opthof for comments on previous drafts.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Interactive overlays of journals and the measurement of interdisciplinarity on the basis of aggregated journal-journal citations

  • Leydesdorff, L.
  • Rafols García, Ismael
  • Chen, C.
sing the option Analyze Results with the Web of Science, one can directly generate overlays onto global journal maps of science. The maps are based on the 10,000+ journals contained in the Journal Citation Reports (JCR) of the Science and Social Sciences Citation Indices (2011). The disciplinary diversity of the retrieval is measured in terms of Rao-Stirling's quadratic entropy (Izsak & Papp, 1995). Since this indicator of interdisciplinarity is normalized between 0 and 1, interdisciplinarity can be compared among document sets and across years, cited or citing. The colors used for the overlays are based on Blondel, Guillaume, Lambiotte, and Lefebvre's (2008) community-finding algorithms operating on the relations among journals included in the JCR. The results can be exported from VOSViewer with different options such as proportional labels, heat maps, or cluster density maps. The maps can also be web-started or animated (e.g., using PowerPoint). The citing dimension of the aggregated journal-journal citation matrix was found to provide a more comprehensive description than the matrix based on the cited archive. The relations between local and global maps and their different functions in studying the sciences in terms of journal literatures are further discussed: Local and global maps are based on different assumptions and can be expected to serve different purposes for the explanation., We thank Nees Jan van Eck and Ludo Waltman for suggestions and comments, and Thomson Reuters for access to the data. Supported by the ESRC project, Mapping the Dynamics of Emergent Technologies (RES-360-25-0076).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Research portfolios in science policy: moving from financial returns to societal benefits

  • Wallace, Matthew
  • Ismael Rafols
[EN] Funding agencies and large public scientific institutions are increasingly using the term "research portfolio" as a means of characterizing their research. While portfolios have long been used as a heuristic for managing corporate R&D (i.e. R&D aimed at gaining tangible economic benefits), they remain ill-defined in a science policy context where research is aimed at achieving societal outcomes. In this article we analyze the discursive uses of the term "research portfolio" and propose some general considerations for their application in science policy. We explore the use of the term in private R&D and related scholarly literature in existing science policy practices, and seek insight in relevant literature in science policy scholarship. While the financial analogy can in some instances be instructive, a simple transposition from the world of finance or of corporate R&D to public research is problematic. However, we do identify potentially fruitful uses of portfolio analysis in science policy. In particular, our review suggests that the concept of research portfolio can indeed be a useful analytical instrument for tackling complex societal challenges. Specifically, the strands of scholarship identified suggest that the use of research portfolio should: i) recognize the diversity of research lines relevant for a given societal challenge, given the uncertainty and ambiguity of research outcomes; ii) examine the relationships between research options of a portfolio and the expected societal outcomes; and iii) adopt a systemic perspective to research portfolios - i.e. examine a portfolio as a functional whole, rather than as the sum of its parts. We argue that with these considerations, portfolio-driven approaches may foster social inclusion in science policy decisions, help deliberation between "alternative" portfolios to tackle complex societal challenges, as well as promote cost-effectiveness and transparency., We thank Tommaso Ciarli, Jochen Glaser, Jordi Molas-Gallart, Richard Wooley, and two anonymous referees for their insightful comments and suggestions. We acknowledge support from the UK Economic and Social Research Council (Grant RES-360-25-0076, Mapping the Development of Emergent Technologies) and the FP7 EU Marie Curie Integration Grant to IR (MapRePort).